Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity

International Journal for Parasitology

Volumn 43, Issue 3-4, 2013, Pages 275-282

  Croese, John ^a   Gaze, Soraya T ^b   Loukas, Alex ^b  

^a TOWNSVILLE HOSPITAL   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Autoimmunity; Coeliac disease; Helminth; Hookworm; IBD

Indexed keywords

GAMMA INTERFERON; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ENDOPARASITE; IMMUNE RESPONSE; IMMUNITY; MEDICINE; NEMATODE; PARASITIC DISEASE;

AUTOIMMUNITY; BYSTANDER EFFECT; CELIAC DISEASE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HISTOPATHOLOGY; HOOKWORM INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INTESTINE MUCOSA; MUCOSAL IMMUNITY; NECATOR AMERICANUS; NONHUMAN; PATIENT SAFETY; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; THERAPY WITH HELMINTHS; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNITY; CELIAC DISEASE; GLUTENS; HUMANS; NECATOR AMERICANUS; THERAPY WITH HELMINTHS;

ANCYLOSTOMATOIDEA; NECATOR AMERICANUS; VERMES;

EID: 84873744694     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.12.005     Document Type: Review

References (58)

1. Anderson R.P., Degano P., Godkin A.J., Jewell D.P., Hill A.V. In vivo antigen challenge in coeliac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 2000, 6:337-342.
2. Anderson R.P., van Heel D.A., Tye-Din J.A., Barnardo M., Salio M., Jewell D.P., Hill A.V. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 2005, 54:1217-1223.
3. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002, 347:911-920.
4. Barone M.V., Zanzi D., Maglio M., Nanayakkara M., Santagata S., Lania G., Miele E., Ribecco M.T., Maurano F., Auricchio R., Gianfrani C., Ferrini S., Troncone R., Auricchio S. Gliadin-mediated proliferation and innate immune activation in coeliac disease are due to alterations in vesicular trafficking. PLoS One 2011, 25:e17039.
5. Barreiro L.B., Quintana-Murci L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 2010, 11:17-30.
6. Bethony J., Chen J., Lin S., Xiao S., Zhan B., Li S., Xue H., Xing F., Humphries D., Yan W., Chen G., Foster V., Hawdon J.M., Hotez P.J. Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. Clin. Infect. Dis. 2002, 35:1336-1344.
7. Bethune M.T., Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog. 2008, 4:e34.
8. Catassi C., Fabiani E., Iacono G., D'Agate C., Francavilla R., Biagi F., Volta U., Accomando S., Picarelli A., De Vitis I., Pianelli G., Gesuita R., Carle F., Mandolesi A., Bearzi I., Fasano A. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with coeliac disease. Am. J. Clin. Nutr. 2007, 85:160-166.
9. Cho J.H., Brant S.R. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 2011, 140:1704-1712.
10. Croese J. Parasites. Textbook of Clinical Gastroenterology and Hepatology 2012, 349-354. Blackwell Publishing Ltd, Oxford. Second ed. C.J. Hawkey, J. Bosch, J.E. Richter, G. Garcia-Tsao, F.K.L. Chan (Eds.).
11. Croese J., Speare R. Intestinal allergy expels hookworms: seeing is believing. Trends Parasitol. 2006, 22:547-550.
12. Croese J., O'Neil J., Masson J., Cooke S., Melrose W., Pritchard D., Speare R. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 2006, 55:136-137.
13. Croese J., Wood M.J., Melrose W., Speare R. Allergy controls the population density of Necator americanus in the small intestine. Gastroenterology 2006, 131:402-409.
14. Crompton D.W.T., Stephenson L.S. Hookworm infection, nutritional status and productivity. Hookworm Disease: Current Status and New Directions 1990, 231-265. Taylor and Francis Ltd, London. G.A. Schad, K.S. Warren (Eds.).
15. Daveson A.J., Jones D.M., Gaze S., McSorley H., Clouston A., Pascoe A., Cooke S., Speare R., Macdonald G.A., Anderson R., McCarthy J.S., Loukas A., Croese J. Effect of hookworm infection on wheat challenge in coeliac disease - a randomised double-blinded placebo controlled trial. PLoS One 2011, 6:e17366.
16. DePaolo R.W., Abadie V., Tang F., Fehlner-Peach H., Hall J.A., Wang W., Marietta E.V., Kasarda D.D., Waldmann T.A., Murray J.A., Semrad C., Kupfer S.S., Belkaid Y., Guandalini S., Jabri B. Coadjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011, 471:220-224.
17. Ebert D. Host-parasite coevolution: insights from the Daphnia-parasite model system. Curr. Opin. Microbiol. 2008, 11:290-301.
18. Fantini M.C., Rizzo A., Fina D., Caruso R., Sarra M., Stolfi C., Becker C., Macdonald T.T., Pallone F., Neurath M.F., Monteleone G. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 2009, 136:1308-1316.
19. Freeman H.J., Chopra A., Clandinin M.T., Thomson A.B.R. Recent advances in celiac disease. World J. Gastroenterol. 2011, 17:2259-2272.
20. Fumagalli M., Pozzoli U., Cagiani R., Comi G.P., Riva S., Clerici M., Bresolin N., Sironi M. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J. Exp. Med. 2009, 206:1395-1408.
21. Fumagalli M., Pozzoli U., Cagiani R., Comi G.P., Bresolin N., Clerici M., Sironi M. The landscape of human genes involved in the immune response to parasitic worms. BMC Evol. Biol. 2010, 10:264.
22. Fumagalli M., Sironi M., Pozzoli U., Ferrer-Admetlla A., Pattini L., Nielsen R. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet. 2011, 7:e1002355.
23. Gaze S., McSorley H., Daveson J., Jones D., Bethony J., Oliveira L.M., Speare R., McCarthy J., Engwerda C.R., Croese J., Loukas A. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog. 2012, 8:e1002520.
24. Geiger S.M., Massara C.L., Bethony J., Soboslay P.T., Correa-Oliveira R. Cellular responses and cytokine production in post-treatment hookworm patients from an endemic area in Brazil. Clin. Exp. Immunol. 2004, 136:334-340.
25. Guandalini S., Setty M. Coeliac disease. Curr. Opin. Gastroenterol. 2008, 24:707-712.
26. Hmida N.B., Ben Ahmed M., Moussa A., Rejeb M.B., Said Y., Kourda N., Meresse B., Abdeladhim M., Louzir H., Cerf-Bensussan N. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease. Am. J. Gastroenterol. 2012, 107:604-611.
27. Hotez P.J., Brooker S., Bethony J.M., Bottazzi M.E., Loukas A., Xiao S. Hookworm infection. N. Engl. J. Med. 2004, 351:799-807.
28. Leibowitz U., Antonovsky A., Medalie J.M., Smith H.A., Halpern L., Alter M. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J. Neurol. Neurosurg. Psychiatry 1966, 29:1-8.
29. Lindfors K., Rauhavirta T., Stenman S., Mäki M., Kaukinen K. In vitro models for gluten toxicity: relevance for coeliac disease pathogenesis and development of novel treatment options. Exp. Biol. Med. (Maywood) 2012, 237:119-125.
30. Lohi S., Mustalahti K., Kaukinen K., Laurila K., Collin P., Rissanen H., Lohi O., Bravi E., Gasparin M., Reunanen A., Mäki M. Increasing prevalence of celiac disease over time. Aliment. Pharmacol. Ther. 2007, 26:1217-1225.
31. Ludwig-Portugall I., Layland L.E. TLRs, Treg, and B Cells, an interplay of regulation during helminth infection. Front. Immunol. 2012, 3:8.
32. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., Londei M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362:30-37.
33. Marsh M.N., Crowe P.T. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin. Gastroenterol. 1995, 9:273-293.
34. Maxwell C., Hussain R., Nutman T.B., Poindexter R.W., Little M.D., Schad G.A., Ottesen E.A. The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. Am. J. Trop. Med. Hyg. 1987, 37:126-134.
35. Maynard C.L., Weaver C.T. Immunology: context is key in the gut. Nature 2011, 471:169-170.
36. McSorley H.J., Loukas A. The immunology of human hookworm infections. Parasite Immunol. 2010, 32:549-559.
37. McSorley H.J., Gaze S., Daveson J., Jones D., Anderson R., Clouston A., Ruyssers N.E., Speare R., McCarthy J.S., Engwerda C.R., Croese J., Loukas A. Suppression of inflammatory immune responses in coeliac disease by experimental hookworm infection. PLoS One 2011, 6:e24092.
38. Mortimer K., Brown A., Feary J., Jagger C., Lewis S., Antoniak M., Pritchard D., Britton J. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am. J. Trop. Med. Hyg. 2006, 75:914-920.
39. Parmar A.S., Lappalainen M., Paavola-Sakki P., Halme L., Färkkilä M., Turunen U., Kontula K., Aromaa A., Salomaa V., Peltonen L., Halfvarson J., Törkvist L., D'Amato M., Saavalainen P., Einarsdottir E. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients. Genes Immun 2012, 10.1038/gene.2012.21.
40. Pritchard D.I., Quinnell R.J., Walsh E.A. Immunity in humans to Necator americanus: IgE, parasite weight and fecundity. Parasite Immunol. 1995, 17:71-75.
41. Quinnell R.J., Bethony J., Pritchard D.I. The immunoepidemiology of human hookworm infection. Parasite Immunol. 2004, 26:443-454.
42. Rashtak S., Murray J.A. Review article: coeliac disease, new approaches to therapy. Aliment. Pharmacol. Ther. 2012, 10:1365-2036.
43. Riddle M.S., Murray J.A., Porter C.K. The incidence and risk of celiac disease in a healthy US adult population. Am. J. Gastroenterol. 2012, 107:1248-1255.
44. Rioux J.D., Abbas A.K. Paths to understanding the genetic basis of autoimmune disease. Nature 2006, 435:584-589.
45. Robinson M.W., Donnelly S., Hutchinson A.T., To J., Taylor N.L., Norton R.S., Perugini M.A., Dalton J.P. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog. 2012, 7:e1002042.
46. Rubio-Tapia A., Ludvigsson J.F., Brantner T.L., Murray J.A., Everhart J.E. The prevalence of celiac disease in the United States. Am. J. Gastroenterol 2012, 10.1038/ajg.2012.219.
47. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
48. Silano M., Di Benedetto R., Maialetti F., De Vincenzi A., Calcaterra R., Trecca A., De Vincenzi M. A 10-residue peptide from durum wheat promotes a shift from a Th1-type response toward a Th2-type response in coeliac disease. Am. J. Clin. Nutr. 2008, 87:415-423.
49. Silano M., Vincentini O., Luciani A., Felli C., Caserta S., Esposito S., Villella V.R., Pettoello-Mantovani M., Guido S., Maiuri L. Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin-dependent agglutination. Pediatr. Res 2012, 10.1038/pr.2012.4.
50. Stene L.C., Honeyman M.C., Hoffenberg E.J., Haas J.E., Sokol R.J., Emery L., Taki I., Norris J.M., Erlich H.A., Eisenbarth G.S., Rewers M. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 2006, 101:2333-2340.
51. Strachan D.P. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
52. Summers R.W., Elliott D.E., Urban J.F., Thompson R., Weinstock J.V. Trichuris suis therapy in Crohn's disease. Gut 2005, 54:87-90.
53. Summers R.W., Elliott D.E., Urban J.F., Thompson R.A., Weinstock J.V. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128:825-832.
54. Troncone R., Jabri B. Coeliac disease and gluten sensitivity. J. Intern. Med. 2011, 269:582-590.
55. Troncone R., Greco L., Mayer M., Mazzarella G., Maiuri L., Congia M., Frau F., De Virgiliis S., Auricchio S. In siblings of coeliac children, rectal gluten challenge reveals gluten sensitization not restricted to coeliac HLA. Gastroenterology 1996, 111:318-324.
56. Tye-Din J., Anderson R. Immunopathogenesis of coeliac disease. Curr. Gastroenterol. Rep. 2008, 10:458-465.
57. Wright V., Bickle Q. Immune responses following experimental human hookworm infection. Clin. Exp. Immunol. 2005, 142:398-403.
58. Zanoni G., Navone R., Lunardi C., Tridente G., Bason C., Sivori S., Beri R., Dolcino M., Valletta E., Corrocher R., Puccetti A. In CeD, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006, 3:e358.